Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;9(1):e002146.
doi: 10.1136/bmjdrc-2021-002146.

Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK

Affiliations

Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK

Antonio González-Pérez et al. BMJ Open Diabetes Res Care. 2021 Oct.

Abstract

Introduction: We aimed to determine the incidence of, and risk factors for all-cause/cardiovascular disease (CVD) mortality, and end-stage renal disease (ESRD) among people with type 2 diabetes with/without diabetic kidney disease (DKD) in the UK general population.

Research design and methods: We undertook a population-based cohort study using primary care UK electronic health records. We followed 8413 people with type 2 diabetes and DKD and a matched comparison cohort of people with type 2 diabetes without DKD. Risk factors for all-cause/CVD mortality (using both cohorts) and ESRD (DKD cohort only) were evaluated by estimating HRs with 95% CIs using Cox regression.

Results: In the DKD cohort (mean age 66.7 years, 62.4% male), incidence rates per 1000 person-years were 50.3 (all-cause mortality), 8.0 (CVD mortality) and 6.9 (ESRD). HRs (95% CIs; DKD vs comparison cohort) were 1.49 (1.35 to 1.64) for all-cause mortality and 1.60 (1.24 to 2.05) for CVD mortality. In general, higher all-cause mortality risks were seen with older age, underweight (body mass index <20 kg/m2), reduced renal function, and cardiovascular/liver disease, and lower risks were seen with being female or overweight. In the DKD cohort, higher risks of ESRD were seen with reduced renal function at baseline, high material deprivation, cancer and non-insulin glucose-lowering drugs, and a lower risk was seen with overweight (≥25 kg/m2).

Conclusions: Annually, one death will occur among every 20 people with type 2 diabetes and DKD. The identified risk factors in this study will help identify people with type 2 diabetes at most risk of death and progression of kidney disease, and help to direct effective management strategies.

Keywords: chronic; epidemiology; kidney failure; mortality; risk factors.

PubMed Disclaimer

Conflict of interest statement

Competing interests: DV is a full-time employee of Bayer Hispania, Barcelona, Spain. LGR, AG-P and MS work for CEIFE (Madrid, Spain), which has received research funding from Bayer. LGR has also received honoraria for serving on advisory boards for Bayer. ML has received research grants from AstraZeneca, DexCom and Novo Nordisk and been consultant for AstraZeneca, DexCom, Eli Lilly, MSD and Novo Nordisk.

Similar articles

Cited by

References

    1. Saeedi P, Petersohn I, Salpea P, et al. . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019;157:107843. 10.1016/j.diabres.2019.107843 - DOI - PubMed
    1. Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease. Clin J Am Soc Nephrol 2017;12:2032–45. 10.2215/CJN.11491116 - DOI - PMC - PubMed
    1. Yee J. Diabetic kidney disease: chronic kidney disease and diabetes. Diabetes Spectrum 2008;21:8–10. 10.2337/diaspect.21.1.8 - DOI
    1. Kähm K, Laxy M, Schneider U, et al. . Health care costs associated with incident complications in patients with type 2 diabetes in Germany. Diabetes Care 2018;41:971–8. 10.2337/dc17-1763 - DOI - PubMed
    1. Vupputuri S, Kimes TM, Calloway MO, et al. . The economic burden of progressive chronic kidney disease among patients with type 2 diabetes. J Diabetes Complications 2014;28:10–16. 10.1016/j.jdiacomp.2013.09.014 - DOI - PubMed

Publication types